• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Federal Trade Commission (FTC)

MedTech 100 roundup: Industry peaks again after new vaccine authorization

December 21, 2020 By Sean Whooley

Recent news in the industry continues to drive its stocks forward, with COVID-19 vaccine developments driving further medtech growth last week. The FDA granted Moderna emergency use authorization for its vaccine candidate on Friday and its rollout to the U.S. is beginning today. Moderna’s vaccine joins the one made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX), which […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceutical, Research & Development, Wall Street Beat Tagged With: AstraZeneca plc, becton dickinson, Boston Scientific, coronavirus, COVID-19, COVID-19 vaccine, Federal Trade Commission (FTC), Johnson and Johnson, MedTech 100 Index, Philips, Stryker, Wright Medical

FTC clears Stryker-Wright Medical deal

December 17, 2020 By Sean Whooley

The U.S. Federal Trade Commission said today that it would require Stryker (NYSE:SYK) and Wright Medical (NSDQ:WMGI) to divest certain assets in their merger. According to a report from MarketScreener, the FTC approved a final order settling charges that Stryker’s proposed acquisition of Wright Medical would violate antitrust law. The companies confirmed the $4.7 billion merger last […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics Tagged With: Federal Trade Commission (FTC), Stryker, Wright Medical

BREAKING: Stryker clears U.S. regulatory hurdle to buy Wright Medical

November 3, 2020 By Chris Newmarker

The Federal Trade Commission announced today that it plans to allow Stryker (NYSE:SYK) to proceed with its planned $4.7 billion acquisition of Wright Medical (NSDQ:WMGI), provided that Stryker divest certain assets to Colfax (NYSE:CFX)/DJO Global. Stryker had proposed selling assets to DJO Global about two months ago as a way to allay FTC concerns that the deal would […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Orthopedics Tagged With: Colfax Corp., DJO Global, Federal Trade Commission (FTC), Stryker, Wright Medical

FTC to refund Neurometrix consumers $3.9M in false ad case

September 9, 2020 By Sean Whooley

The Federal Trade Commission announced that it is refunding NeuroMetrix (NSDQ:NURO) consumers nearly $3.9 million after false advertising. NeuroMetrix marketed its Quell transcutaneous electrical nerve stimulation device as a clinically proven and FDA-cleared treatment for widespread chronic pain relief when placed below the knee, according to the FTC, which said that the company lacks scientific evidence […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

Stryker may sell certain assets to enable Wright Medical purchase

September 2, 2020 By Sean Whooley

Stryker (NYSE:SYK) has proposed a plan to divest certain assets to Colfax (NYSE:CFX)/DJO Global in an effort to complete its acquisition of Wright Medical (NSDQ:WMGI). Kalamazoo, Mich.-based Stryker’s proposed divestitures of its STAR total ankle replacement product, plus related assets, and its finger joint replacement products, is in connection with the Federal Trade Commission’s review of the ongoing effort […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Wall Street Beat Tagged With: Colfax Corp., DJO Global, Federal Trade Commission (FTC), Stryker, U.K. Competition and Markets Authority, Wright Medical

Federal Trade Commission sues online retailer over its PPE shipment speed claims

July 13, 2020 By Chris Newmarker

The Federal Trade Commission has sued online retailer SuperGoodDeals.com — claiming that it falsely promised consumers next-day shipping of facemasks and other personal protective equipment amid the COVID-19 pandemic. SuperGoodDeals’ website starting in March said PPE was “in stock,” and touted “Pay Today, Ships Tomorrow” — but it often took weeks for PPE merchandise to […]

Filed Under: Featured, Legal News Tagged With: coronavirus, COVID-19, Federal Trade Commission (FTC), SuperGoodDeals.com

U.K. probing Stryker-Wright Medical merger

May 20, 2020 By Nancy Crotti

The U.K. Competition and Markets Authority has begun an investigation into the proposed $4.7 billion merger of Stryker (NYSE:SYK) and Wright Medical (NSDQ:WMGI). Announced in November 2019, the merger would have Stryker pay $30.75 per share to acquire all of the issues and outstanding ordinary shares of Wright Medical. With outstanding convertible notes, total enterprise value is […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics, Regulatory/Compliance, Wall Street Beat Tagged With: Federal Trade Commission (FTC), Stryker, U.K. Competition and Markets Authority, Wright Medical

AbbVie gains U.S. nod for $63B Allergan takeover

May 6, 2020 By Nancy Crotti

Pharmaceutical giant  AbbVie (NYSE:ABBV) has won U.S. antitrust approval for its  purchase of Allergan (NYSE:AGN) for $63 billion in cash and stock. The purchase is seen as a hedge against the impending expiration of U.S. patents on AbbVie’s blockbuster drug, Humira. North Chicago-based AbbVie announced the deal in June 2019, but ran up against U.S. […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Pharmaceutical, Wall Street Beat Tagged With: AbbVie, Allergan, AstraZeneca plc, Eli Lilly & Co., Federal Trade Commission (FTC), Johnson & Johnson

NeuroMetrix settles $4m false advertising case with FTC

March 4, 2020 By Nancy Crotti

Pain-treating TENS device company NeuroMetrix (NSDQ:NURO) has agreed to pay at least $4 million to settle a false advertising case brought by the Federal Trade Commission FTC. The commission said today that the Woburn, Mass.-based company also agreed to stop making deceptive claims that its Quell device treats pain throughout the body when placed below the […]

Filed Under: Business/Financial News, Featured, Legal News, Neuromodulation/Neurostimulation, Pain Management Tagged With: Federal Trade Commission (FTC), Neurometrix

FDA, FTC want to encourage competition in biologics market

February 3, 2020 By Sean Whooley

The FDA and U.S. Federal Trade Commission (FTC) announced today that they signed a joint statement to encourage collaboration in support of a robust marketplace for biological products, including the critical adoption of biosimilars and interchangeable products. The two agencies said the statement sets out to address false or misleading promotion about biosimilars within the […]

Filed Under: Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: FDA, Federal Trade Commission (FTC)

FTC upping scrutiny of proposed Stryker, Wright Medical merger

January 2, 2020 By Sean Whooley

An SEC filing today showed that the Federal Trade Commission is upping its scrutiny of the proposed merger between Stryker (NYSE:SYK) and Wright Medical (NSDQ:WMGI) that is worth up to $4.7 billion in cash. After Stryker filed a premerger notification and report form with the FTC on Dec. 16, 2019, the FTC sent a second request to […]

Filed Under: Business/Financial News, Featured, Legal News, Mergers & Acquisitions Tagged With: Federal Trade Commission (FTC), Stryker, Wright Medical

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS